Clinical impact of native T1 mapping for detecting myocardial impairment in takotsubo cardiomyopathy

Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1147-1155. doi: 10.1093/ehjci/jez034.

Abstract

Aims: To investigate the clinical impact of T1 mapping for detecting myocardial impairment in takotsubo cardiomyopathy (TTC) over time.

Methods and results: In 23 patients with the apical ballooning type of TTC, the following 3T magnetic resonance (MR) examinations were performed at baseline and 3 months after TTC onset: T2-weighted imaging, T2 mapping, native T1 mapping, extracellular volume fraction (ECV), and late gadolinium enhancement. Eight healthy controls underwent the same MR examinations. Serial echocardiography was performed daily for ≥7 days and monthly until 3 months after onset. The median time from onset to MR examination was 7 days. During the acute phase, patients had, relative to controls, higher native T1 (1438 ± 162 vs. 1251 ± 90 ms, P < 0.001), ECV (35 ± 5% vs. 29 ± 4%, P < 0.001), and T2 (90 ± 34 vs. 68 ± 12 ms, P < 0.001) for the entire heart. Per-region analysis showed that higher native T1 and T2 in the basal region were correlated with lower left ventricular ejection fraction (r = -0.599, P = 0.004 and r = -0.598, P = 0.003, respectively). Receiver operator characteristic analysis showed that the area under the curve for native T1 (0.96) was significantly larger than that for T2 (0.86; P = 0.005) but similar to that for ECV (0.92; P = 0.104). At 3-month follow-up, native T1, ECV, and T2 in the apical region remained significantly elevated in all patients with TTC. The number of left ventricular (LV) segments with elevated native T1 (cut-off value 1339 ms) was significantly correlated with prolonged LV wall motion recovery time (r = 0.494, P = 0.027).

Conclusion: Characterization of myocardium with native T1 mapping is a promising method for predicting LV wall motion restoration in TTC.

Keywords: T1 mapping; magnetic resonance imaging; takotsubo cardiomyopathy.

MeSH terms

  • Biomarkers / blood
  • Case-Control Studies
  • Comorbidity
  • Contrast Media
  • Echocardiography
  • Electrocardiography
  • Female
  • Gadolinium DTPA
  • Humans
  • Magnetic Resonance Imaging, Cine / methods*
  • Male
  • Middle Aged
  • Risk Factors
  • Stroke Volume
  • Takotsubo Cardiomyopathy / diagnostic imaging*

Substances

  • Biomarkers
  • Contrast Media
  • Gadolinium DTPA